DK0754054T3 - Antirestenosis-protein - Google Patents

Antirestenosis-protein

Info

Publication number
DK0754054T3
DK0754054T3 DK94921886T DK94921886T DK0754054T3 DK 0754054 T3 DK0754054 T3 DK 0754054T3 DK 94921886 T DK94921886 T DK 94921886T DK 94921886 T DK94921886 T DK 94921886T DK 0754054 T3 DK0754054 T3 DK 0754054T3
Authority
DK
Denmark
Prior art keywords
pct
date
serp
sec
antirestenosis
Prior art date
Application number
DK94921886T
Other languages
English (en)
Inventor
D Grant Mcfadden
Alexandra Lucas
Original Assignee
Viron Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Viron Therapeutics Inc filed Critical Viron Therapeutics Inc
Application granted granted Critical
Publication of DK0754054T3 publication Critical patent/DK0754054T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Passenger Equipment (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK94921886T 1994-04-08 1994-04-08 Antirestenosis-protein DK0754054T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1994/003895 WO1995027503A1 (en) 1994-04-08 1994-04-08 Antirestenosis protein

Publications (1)

Publication Number Publication Date
DK0754054T3 true DK0754054T3 (da) 2002-10-14

Family

ID=22242439

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94921886T DK0754054T3 (da) 1994-04-08 1994-04-08 Antirestenosis-protein

Country Status (10)

Country Link
US (1) US5686409A (da)
EP (1) EP0754054B1 (da)
JP (1) JPH10504015A (da)
AT (1) ATE219943T1 (da)
CA (1) CA2187444C (da)
DE (1) DE69430924T2 (da)
DK (1) DK0754054T3 (da)
ES (1) ES2176250T3 (da)
PT (1) PT754054E (da)
WO (1) WO1995027503A1 (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5939525A (en) * 1995-03-27 1999-08-17 Viron Therapeutics, Inc. Methods of treating inflammation and compositions therefor
US6818016B1 (en) * 1997-06-27 2004-11-16 The Regents Of The University Of Michigan Methods for coating stents with DNA and expression of recombinant genes from DNA coated stents in vivo
JP2003508489A (ja) * 1999-09-09 2003-03-04 ハダジツト・メデイカル・リサーチ・サービシズ・アンド・デベロツプメント・カンパニー・リミテツド 創傷治癒の増進
WO2001030379A2 (en) 1999-10-27 2001-05-03 Alexandra Lucas Compositions and methods for preventing and treating transplant rejection
WO2001039790A1 (en) * 1999-12-02 2001-06-07 Viron Therapeutics, Inc. Methods of treating inflammation and compositions therefor
JP2004509171A (ja) 2000-09-29 2004-03-25 ゾーン、　ロバート　ズィー． 炎症及び免疫反応の治療方法及びその組成物
AU1174402A (en) 2000-10-11 2002-04-22 Viron Therapeutics Inc Nucleic acid molecules and polypeptides for immune modulation
DK1339737T3 (da) * 2000-12-04 2007-10-15 Viron Therapeutics Inc Immunomodulatorisk protein dannet ud fra Yaba-abetumorvirus
US7718368B2 (en) * 2000-12-04 2010-05-18 Viron Therapeutics Inc. Immunomodulatory protein and useful embodiments thereof
US7285530B2 (en) 2004-10-21 2007-10-23 Viron Therapeutics, Inc. Use of SERP-1 as an antiplatelet agent
US8251876B2 (en) 2008-04-22 2012-08-28 Hill-Rom Services, Inc. Breathing exercise apparatus
CA2773744A1 (en) * 2009-09-16 2011-03-24 Viron Therapeutics Inc. Methods of treating a patient receiving a cardiac stent implant
US9180271B2 (en) 2012-03-05 2015-11-10 Hill-Rom Services Pte. Ltd. Respiratory therapy device having standard and oscillatory PEP with nebulizer

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5171217A (en) * 1991-02-28 1992-12-15 Indiana University Foundation Method for delivery of smooth muscle cell inhibitors

Also Published As

Publication number Publication date
ATE219943T1 (de) 2002-07-15
EP0754054A1 (en) 1997-01-22
EP0754054B1 (en) 2002-07-03
ES2176250T3 (es) 2002-12-01
DE69430924T2 (de) 2003-02-27
CA2187444A1 (en) 1995-10-19
JPH10504015A (ja) 1998-04-14
CA2187444C (en) 2008-07-08
DE69430924D1 (de) 2002-08-08
US5686409A (en) 1997-11-11
PT754054E (pt) 2002-10-31
WO1995027503A1 (en) 1995-10-19

Similar Documents

Publication Publication Date Title
ATE209483T1 (de) Behandlung von multipler sklerose
ATE219943T1 (de) Antirestenoses protein
MY131796A (en) Use of glp-1 or analogs in treatment of myocardial infraction
ATE113834T1 (de) Zusammensetzung zur behandlung der schizophrenie.
SE9402453D0 (sv) New pharmaceutical preparation
AU1373499A (en) Use of 9-deoxy-2', 9-alpha-methano-3- oxa-4,5,6- trinor-3, 7-(1',3'-interphenylene) -13,14-dihydro- prostaglandin f1 to treat peripheral vascular disease
DE69530403D1 (de) Analogen des keratinozytenwachstumfaktors
PL323798A1 (en) Application of derivatives of vitamin d4 in treating skin diseases
FR2739029B1 (fr) Nouvelle application therapeutique des composes antimineralo-corticoides
DE69424777D1 (de) 3,4-diarylchromane zur behandlung von dermatitis
SE9502219D0 (sv) Novel medical use
DE69625682D1 (de) Verfahren zur behandlung von entzündungen und zusammensetzungen dafür
US5798392C1 (en) Sulfonyl fluorides for the treatment of alzheimer's disease
SE9504267D0 (sv) New therapeutic use
TR199801801T2 (xx) Madde k�t�ye kullan�m�n�n tedavisi.
ATE184487T1 (de) Transdermales therapeutisches system für silatranverbindungen